✦ LIBER ✦

Rationale and design of the Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure (EMPHASIS-HF)

✍ Scribed by Zannad, Faiez; McMurray, John J.V.; Drexler, Helmut; Krum, Henry; van Veldhuisen, Dirk J.; Swedberg, Karl; Shi, Harry; Vincent, John; Pitt, Bertram

Book ID: 121655880
Publisher: Oxford University Press
Year: 2010
Tongue: English
Weight: 168 KB
Volume: 12
Category: Article
ISSN: 1388-9842
DOI: 10.1093/eurjhf/hfq049

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Eplerenone and Atrial Fibrillation in Mi

Eplerenone and Atrial Fibrillation in Mild Systolic Heart Failure: Results From the EMPHASIS-HF (Eplerenone in Mild Patients Hospitalization And SurvIval Study in Heart Failure) Study

✍ Karl Swedberg; Faiez Zannad; John J.V. McMurray; Henry Krum; Dirk J. van Veldhui 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 493 KB

Incidence, Determinants, and Prognostic

Incidence, Determinants, and Prognostic Significance of Hyperkalemia and Worsening Renal Function in Patients With Heart Failure Receiving the Mineralocorticoid Receptor Antagonist Eplerenone or Placebo in Addition to Optimal Medical Therapy: Results From the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF)

✍ Rossignol, P.; Dobre, D.; McMurray, J. J. V.; Swedberg, K.; Krum, H.; van Veldhu 📂 Article 📅 2014 🏛 Ovid Technologies Wolters Kluwer -American Heart A 🌐 English ⚖ 786 KB

The effect of eplerenone on all-cause mo

The effect of eplerenone on all-cause mortality and heart failure hospitalization in the eplerenone post-acute myocardial infarction heart failure efficacy and survival study (EPHESUS)

✍ Faiez Zannad; Mihai Gheorghiade; Henry Krum; Teng-Chiao Chu; Rajiv Patni; Bertra 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 59 KB

Investigating Pain in Heart Failure Pati

Investigating Pain in Heart Failure Patients: Rationale and Design of the Pain Assessment, Incidence & Nature in Heart Failure (PAIN-HF) Study

✍ Sarah J. Goodlin; Sue Wingate; Susan J. Pressler; John R. Teerlink; C. Porter St 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 176 KB

Organized program to initiate lifesaving

Organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF): rationale and design

✍ Gregg C Fonarow; William T Abraham; Nancy M Albert; Wendy A Gattis; Mihai Gheorg 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 276 KB

Organized program to initiate lifesaving

Organized program to initiate lifesaving treatment in hospitalized patients with heart failure (OPTIMIZE-HF): rationale and design

✍ Gregg C Fonarow; William T Abraham; Nancy M Albert; Wendy A Gattis; Mihai Gheorg 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 276 KB

Heart failure (HF) affects >5 million patients in the United States, and its prevalence is increasing every year. Despite the compelling scientific evidence that angiotensin-converting enzyme inhibitors and β-blockers reduce hospitalizations and mortality rates in patients with HF, these lifesaving